Evidence map›Paper›PMID 35456551›Full record

ArticlePharmaceutics2022

The Effects of Various Food Products on Bisphosphonate's Availability.

Monika Zielińska, Grzegorz Garbacz, Jaroslaw Sczodrok, Adam Voelkel

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Monika ZielińskaInstitute of Chemical Technology and Engineering, Poznań University of Technology, ul. Berdychowo 4, 60-965 Poznan, Poland.ORCID 0000-0002-8850-6270
Grzegorz GarbaczPhysiolution Polska sp. z o.o., Piłsudskiego 74, 50-020 Wrocław, Poland.ORCID 0000-0003-4511-0329
Jaroslaw SczodrokPhysiolution GmbH, Walther-Rathenau-Straße 49 a, 17489 Greifswald, Germany.
Adam VoelkelInstitute of Chemical Technology and Engineering, Poznań University of Technology, ul. Berdychowo 4, 60-965 Poznan, Poland.ORCID 0000-0002-6536-8952
Poznań University of Technology · PL

Funding

European Union's Horizon 2020 Research and Innovation program under the Marie Skłodow-ska-Curie grant agreement -Ministry of Science and Higher Education of Poland 778051
6 · The paper itself

Abstract

The bioavailability of orally administered bisphosphonates is very low (<1%) due to their short absorption window in the proximal duodenum and high affinity for food. Food ingredients are able to bind the drug, but the presence of food extends the residence time of bisphosphonates in the absorption window. Therefore, the main goal of this study is to select a group of food products that are characterized by low binding affinity to bisphosphonates and thus will not reduce their availability upon concomitant administration. For this purpose, a combination of three methods was applied: (1) evaluation of sorption capacity for rows of digested food samples in a simulated intestinal environment; (2) evaluation of drug availability in simulated chyme; and (3) evaluation of drug availability using a simulating needle device. The results indicate that food products such as egg white and white bread are most suitable for consumption during oral bisphosphonate intake.

Indexed as

bisphosphonatesdrug bioavailabilitygastrointestinal absorption

Identifiers

PMID35456551
PMCPMC9029784
OpenAlexW4220784144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.